Wyeth, Schwartz Ask 10th Circ. To Nix Suit Over Generic Reglan

Law360, New York (August 30, 2012, 9:32 PM EDT) -- Wyeth Inc. and Schwarz Pharma Inc. on Wednesday asked the Tenth Circuit to toss for lack of jurisdiction an appeal by an Oklahoma couple who claim the pharmaceutical companies failed to warn the public about serious side effects from generic versions of their brand-name anti-heartburn drug Reglan.

In their brief before the Tenth Circuit, the companies said Susan and Steve Schrock’s appeal of an Oklahoma federal court’s 2009 decision to grant Wyeth and Schwarz summary judgment is untimely since it comes three years afterward. As such, the appeal should be dismissed for lack of jurisdiction, the brief said.

The Oklahoma federal...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Oklahoma Western

Nature of Suit

Personal Inj. Prod. Liability

Judge

Subscribers Only

Date Filed

April 30, 2008

Law Firms

Companies